Malaria, caused by Plasmodium, is responsible for more than a million deaths all over the world. As per WHO’s ten facts on malaria, nearly half of the world’s population is at risk of malaria. Consequently, there is a need to identify and develop antimalarial therapeutics. At Infiniti Research, our experts performed a market intelligence study to understand the demand-supply landscape of the antimalarial treatment market across tropical countries. Governments have also implemented various elimination strategies to reduce the number of patients suffering from the disease.
Antimalarial Drugs Market Trends
The global antimalarial drug market to decline between 2014-2018 across regions as the number of patients suffering from malaria is decreasing.
Antimalarial drugs are used for the prevention of malarial infections. These drugs target the erythrocytic stage of malaria infection. Due to several international bodies and federal governments taking preventive measures to control the disease, there has been a stark decline in the demand for antimalarial drugs. Also, early diagnosis and treatment add to the above reason. Our experienced market potential assessment team at Infiniti Research tracked recent developments and innovations in the market through a meticulous process of collecting and analyzing information from exhaustive primary and secondary research methodologies.
Nigeria – The leading market for antimalarial drugs in 2014, followed by DRC and Indonesia.
Young children, pregnant women, and travelers from malaria-free areas are vulnerable to the disease. Access to diagnostic centers and treatment are the major concerns for the African population. Malaria was a major public health issue in Nigeria, the DRC, Uganda, and Ghana, which reported several cases and deaths related to the disease in 2013. Our analysts spoke to stakeholders responsible for the sales and distribution of antimalarial drugs to understand how the antimalarial drugs market would perform in the short and long term across various regions.
By evaluating a broad range antimalarial drugs market of published literature to develop an initial hypothesis, Infiniti’s market potential assessment team approached numerous market stakeholders and conducted in-depth primary and secondary research to determine the prescription patterns, key treatment methods used, and the trends affecting the antimalarial drugs market.